We are live on
!
Find out more
MGB
Mass General Brigham Portfolio holdings
AUM
$361M
This Fund
S&P 500
This Quarter
Est. Return
+8.17%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
-$18.4M
(-14%)
Cap. Flow
-$25.2M
Cap. Flow
% of AUM
-22.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
3
Increased
–
Reduced
2
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Samsara
IOT
|
+$8.38M |
| 2 |
Flywire
FLYW
|
+$1.75M |
| 3 |
GTM
ZoomInfo Technologies
GTM
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$10.1M |
| 3 |
Revolution Medicines
RVMD
|
+$7.33M |
| 4 |
UiPath
PATH
|
+$915K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.71% |
| 2 | Financials | 8.39% |
| 3 | Consumer Discretionary | 0.68% |
| 4 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Core S&P 500 ETF
IVV
$904B
| $53.8M | 48.9% |
120,617
-44,185
| -27% | -$18.6M |
|
|
2
iShares Core US Aggregate Bond ETF
AGG
$138B
| $32.2M | 29.31% |
328,893
-101,776
| -24% | -$10.1M |
|
|
3
Samsara
IOT
$22.9B
| $10.5M | 9.53% |
+378,035
| New | +$8.38M |
|
4
Coinbase
COIN
$39.3B
| $9.23M | 8.39% |
128,947
| – | – |
|
|
5
Flywire
FLYW
$2.12B
| $1.82M | 1.65% |
+58,488
| New | +$1.75M |
|
|
GTM
6
ZoomInfo Technologies
GTM
$1.12B
| $1.69M | 1.53% |
+66,415
| New | +$1.57M |
|
7
Rivian
RIVN
$23.1B
| $751K | 0.68% |
45,074
| – | – |
|
|
8
UiPath
PATH
$7.91B
| – | – |
-52,089
| Closed | -$915K |
|
|
9
Revolution Medicines
RVMD
$44B
| – | – |
-338,191
| Closed | -$7.33M |
|
Similar funds
PI
PWC
MCM
RA
A6
WTFG
5VM
SIAG
Mass General Brigham's Q2 2023 Portfolio in Review
As of Q2 2023, Mass General Brigham held 9 positions worth $110M, down 14% from $128M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mass General Brigham withdrew a net $25.2M in Q2 2023, closing 2 positions and reducing 2 holdings. Its most notable exit was Revolution Medicines, an estimated $7.33M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 0.71% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Mass General Brigham opened a new position in Samsara worth $10.5M.
- Mass General Brigham's largest Q2 2023 buy was Samsara: 378,035 shares worth $10.5M.
- Mass General Brigham's biggest Q2 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $18.6M.
- Mass General Brigham fully exited Revolution Medicines in Q2 2023, selling an estimated $7.33M.
- Mass General Brigham's ten largest holdings make up 100% of its $110M portfolio in Q2 2023.
- Mass General Brigham opened 3 new positions and closed 2 in Q2 2023.
- Mass General Brigham's portfolio value fell 14% quarter-over-quarter to $110M.
Based on Mass General Brigham's 13F filing for Q2 2023, filed 21 Jul 2023.